Bovine Mastitis Market, By Type (Clinical and Sub-Clinical), By Product (Antibiotics and Others), By Route of Administration (Intramammary and Systemic), By Therapy (Lactating Period and Dry Period (Antibiotics and Others)), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Forecast till 2029

Report Code: PMI453020 | Publish Date: August 2023 | No. of Pages: 168

Global Bovine Mastitis Market Companies

  • Merck & Co., Inc. (MSD Animal Health)
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Elanco
  • Ceva
  • West Way Health.

Recent News:

  • In October 2022, NovaQuest Capital Management invested more than $20 million in Mileutis Ltd, an Israeli biopharmaceutical company, to help reduce antibiotic use in animals. Mileutics is in the advanced stages of developing products to treat and prevent bovine mastitis.
  •  In August 2022, PortaCheck launched the PortaReader, a handheld device that detects subclinical bovine mastitis in cow's milk.  PortaReader detects subclinical mastitis in fresh cow milk samples right on the farm.
  • In August 2021, Dairy Australia, Coles, Food Agility CRC, University of Sydney, University of Technology Sydney and Charles Sturt University joined forces to reduce antibiotic use in the dairy supply chain and improve health and well-being. Such as managing dairy cows with mastitis. These organizations used the Mastitis Clinical Decision Support Tool Project, an AI-based tool for clinical mastitis management.